Integra LifeSciences Holdings Corporation is a world-leading medical technology company dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a broad portfolio of products and solutions for neurosurgery, extremity orthopedics, and reconstructive and general surgery. Their innovative technologies are used in hospitals and surgical centers worldwide to improve patient outcomes, addressing conditions such as brain tumors, traumatic brain injury, dural repair, hydrocephalus, peripheral nerve repair, and chronic wounds.
Serves as the global corporate headquarters, housing executive leadership, global strategy, corporate R&D oversight, and key administrative and support functions.
Modern corporate campus designed to foster collaboration and innovation, likely featuring advanced research and development support facilities and collaborative workspaces.
The work culture at Integra LifeSciences's headquarters emphasizes innovation, a strong focus on patient outcomes, and collaboration across departments. Employees are typically driven by the company's mission to improve lives through medical technology, fostering an environment of continuous learning and ethical practice.
The Princeton headquarters is strategically located within New Jersey's prominent life sciences corridor, providing access to a rich talent pool and a vibrant ecosystem of research institutions and industry partners. It acts as the central nervous system for Integra's global operations and strategic decision-making.
Integra LifeSciences operates on a global scale, with direct commercial operations, R&D facilities, and manufacturing sites in the Americas, Europe, and Asia-Pacific. The company's products are sold in over 130 countries through a combination of direct sales forces and distributor networks. Key functions supported globally include clinical research, product development, manufacturing and supply chain management, sales and marketing, and extensive clinical and customer support services to healthcare professionals worldwide.
1100 Campus Road
Princeton
New Jersey
USA
Address: 311 Enterprise Drive, Plainsboro, NJ 08536, USA
Key site for North American manufacturing and R&D, supporting global product supply and innovation in tissue technologies.
Address: Parc Technologique de la Porte des Alpes, Bâtiment l'Initial, 455 Allée des Foyes, 69800 Saint-Priest, France
Coordinates Integra's commercial activities and supports market expansion across the diverse EMEA landscape.
Address: 300 Federal Street, Andover, MA 01810, USA
Drives innovation and provides critical support for neurosciences products within the US market and globally.
Address: 4150 South Service Road, Suite 100, Burlington, ON L7L 4X5, Canada
Manages commercial operations and customer relationships within the Canadian healthcare market.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Integra' leadership includes:
Integra has been backed by several prominent investors over the years, including:
Integra LifeSciences has seen key leadership transitions over the past year, particularly within its finance organization, aimed at strengthening its executive team to support strategic growth and operational excellence.
Discover the tools Integra uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Integra LifeSciences commonly uses a standard corporate email format, typically combining an employee's first name and last name, separated by a period, followed by the company domain.
first.last@integralife.com
Format
jane.doe@integralife.com
Example
85%
Success rate
Integra LifeSciences Investor Relations • April 25, 2024
Integra LifeSciences announced its financial results for the first quarter ended March 31, 2024. The company reported revenues of $380.9 million, reflecting a decrease of 0.9% on a reported basis and an increase of 0.4% on an organic basis compared to the first quarter of 2023....more
Integra LifeSciences Investor Relations • May 8, 2024
Integra LifeSciences announced that Jan De Witte, president and chief executive officer, and Lea Knight, executive vice president and chief financial officer, will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024....more
Integra LifeSciences Investor Relations • February 26, 2024
Integra LifeSciences announced the appointment of Lea Daniels Knight as its new executive vice president and chief financial officer, effective February 26, 2024. Ms. Knight succeeds Carrie Anderson, who departed the company....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Integra, are just a search away.